withdrawal from tirzepatide People Who Stopped Taking the Weight Loss Drug Regained Nearly Half the Weight They Lost How the weight loss drug

As an incretin hormone, GLP-1 enhances insulin secretion, suppresses glucagon release, delays gastric emptying, and modulates appetite regulation

ZhuHBiDZhangYKongCDuJWuXet al

**Reduction in Fatty Liver Disease**: Weight loss with these medications often leads to decreased liver fat, potentially improving or reversing non-alcoholic fatty liver disease[3]

Bien quune proportion assez importante des patients aient rapport un certain nombre deffets secondaires, en particulier au niveau gastro-intestinal (nauses, vomissement, diarrhes), ces effets indsirables ont cependant tendance samenuiser avec le temps et ladhrence au traitement demeure leve, avec environ 5 % des patients qui cessent le traitement en raison des effets secondaires

Available from: Buracchio T, Campbell M, Krudys K